Ultrasound Flashcards

1
Q

What are the 5 ultrasound features that can help calculate the RMI score?

A
  1. Mutilocular cyst
  2. Presence of solid areas
  3. Bilaterality of lesions
  4. Presence of ascites
  5. Presence of intra-abdominal metastases

SOGC 230

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In the first trimester, if the EDC from the LMP and the ultrasound calculated CRL is different by more than how many days should the EDC be changed?

A

Before 9 weeks, if there is a discrepancy of more than 5 days between the GA of the LMP and the CRL, then we should use the EDC of the CRL from the ultrasound.
Between 9 and 13+6 weeks, the discrepancy should be more than 7 days.

Berghella Obs Chapter 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

At how many weeks of gestation should the nuchal translucency be performed?

A

Between 10+6 and 13+6 weeks.
Or CRL of 45-84mm

Berghella Obs Chapter 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the 3 diagnostic criteria for embryonic or anembryonic demise in the first trimester.

A

1) Mean gestational sac diameter >=25mm without embryo
2) CRL>= 7 mm with no visible cardiac activity

3) No embryo with cardiac activity if:
>= 14 days after gestational sac without yolk sac
OR >=11 days after gestational sac with yolk sac

Berghella Obs Chapter 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the best non-invasive screening test for fetal anemia?

A

Fetal middle cerebral artery (MCA) peak systolic velocity (PSV)

Berghella Obs Chapter 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name indications to send pregnant women for fetal echocardiography. (13)

A

Maternal indications:

1) Autoimmune antibodies (anti-Ro/anti-La)
2) Familial inherited disorders (22q11.2 deletion syndrome)
3) IVF
4) Metabolic disease (pregestational diabetes, phenylketonuria)
5) Teratogen exposure (e.g. retinoids, lithium)

Fetal indications:

6) Abnormal cardiac screening exam
7) First degree relative of fetus with CHD
8) Abnormal heart rate or rhythm
9) Fetal chromosome anomaly
10) Extracardiac anomaly
11) Fetal hydrops
12) Increased nuchal translucency
13) Monochorionic twins

Berghella Obs Chapter 4, p.55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the rate of PTB in Canada?

A

8%

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the incidence of short cervix defined as <25mm at 24wk in Canada?

A

3%

based on one study only
limited data in the Canadian population

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Screening for short cervix with TVUS has a good:

?sensitivity, specificity, NNV, PPV

A

specificity
NPV

In the Canadian study, Sens 13%, Spec 97%, PPV 19%, NPV 95%.

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In a low-risk nulliparous population, CL <25mm at 16-22wk identified % PTB?

A

8%

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If changing the focus from general population CL screening to patients with RF for PTB (LEEP, previous PTB, uterine anomaly), which statistical parameters will increase

A

PPV

Sensitivity and specificity are not influenced by the incidence in the population
NNT will likely decrease

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What techniques can prevent PTB in patients with short CL by US at 24wk?

A

vaginal progesterone
cerclage if prior PTB
cerclage= weak evidence, not approved by Health Canada for this reason

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Comment on use of CL as a screening tool.

Use the elements of a screening test

A
  • easy to do: yes, acceptable to patients and safe
  • accessible: no, only large and medium centres can offer
  • condition prevalent in the population: no, unclear –incidence in the Canadian population, only one study showed 3% CL <25mm 16-22wk
  • actual detection of PTB: no, only detect 8% of PTB
  • presence of a treatment: yes, PV progesterone
  • cost effective: unknown; 4 studies looked at this and said yes, however based on a prevalence that is higher than actually described in the literature.

SOGC 375

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SOGC T1 US refers to US up to how many weeks

A

14 wk GA

SOGC 374

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why do HEG patients need T1 US

A

rule out:

  • SAB
  • ectopic
  • molar
  • twins

assess:
- dating
- early anatomy

SOGC 374

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why do T1 TAB needs US

A
  • confirm IUP
  • confirm dating (eg. mifemyso only at certain GA)

SOGC 374

17
Q

List reasons for T1 US

A
dating
rule out twins: if so, access chorionicity, amnionicity
rule out molar
SAB/TAB assessments
IUP- rule out ectopic, C-scar
accreta assessment
early anatomy, NT screen
prior to procedure: cerclage, CVS, reduction
NOT for diagnosis of pregnancy
pelvic mass assessment
PET screening 

SOGC 374

18
Q

What are the components of T1 PET risk assessment algorithm?

A
Centres that have expertise and resources should do it.
Includes:
-bilat UA dopplers (PI)
-maternal MAP
-maternal PAPP-a
-PGF 11-14 wk
-maternal history

this algorithm detects 77% early onset PET, 43% term PET, FP rate of 10%.

SOGC 374

19
Q

What is the risk reduction in PTB when vaginal progesterone is prescribed for CL <25mm at <24wk?

A

decreases risk by 38% to deliver by 33wk

SOGC 375

20
Q

A 35yo G2P1 at 19+3 with previous PTB at 27 weeks is found to have CL 22mm at 19week anatomy US. What is the indicated treatment?

A

cerglage
OR
vaginal progesterone

SOGC 373

21
Q

What are indications and contraindications for emergency cerclage?

A

cervix >1cm open
up to 4+ cm. before 24 weeks

no contractions
no chorio
normal anatomy, N serum/NT screen

SOGC 373

22
Q

What are the indications for cerclage removal?

A

routine 36-38wk
PTL not responding to tocolysis
strong suspicion of sepsis
PPROM within 48h (allows for beta; cannot wait if elevated CRP)

SOGC 373

23
Q

What are maternal risk factors for cervical insufficiency?

A
previous T2 loss/ PTB
hx of LEEP
hx of TAB
hx of cervical manipulation
CS for FTD
cervical tear/laceration 
DES exposure
PPROM<32weeks
congenital uterine anomaly
connective tissue disorder

index pregnancy RF for PTB: funnel, short cervix

SOGC 373

24
Q

What are the steps to do prior to vaginal cerclage?

A

verify: N anatomy, viable
low risk trisomy (NT, serum screen)
UA, UCx
vaginal culture for BV

SOGC 373

25
Q

What infection should you screen for in a patient with PTB?

A

BV
(in addition to routine UCx, GC)

SOGC 373

26
Q

What are the indications for an abdominal cerclage?

A

previous trachelectomy
3+ mid-trimester losses or early PTB only if: previous vaginal cerclage unsuccessful

SOGC 373

27
Q

What is the effect of having a cerclage on FFN?

discuss PPV and NPV effects

A

worse PPV
NPV not affected

SOGC 373

28
Q

When should the 1st T2 US be scheduled in a patient with a previous 23 wk loss?

A

16 weeks or 2 weeks prior to T2 loss, whichever is earlier. Then Q7-14 days.

SOGC 373

29
Q

What kind of frequency and energy are the sound waves for US?

A

high-frequency, low energy

SOGC 304

30
Q

Should you do US for determining gender?

A

Not for this sole reason
not for fun
US use only for diagnostic/screening- kept to minimum
only theoretical risk

SOGC 304